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The increased white adipose tissue (WAT) mass
associated with obesity is the result of both hyper-
plasia and hypertrophy of adipocytes. However, the
mechanisms controlling adipocyte number are
unknown in part because the identity of the physio-
logical adipocyte progenitor cells has not been
defined in vivo. In this report, we employ a variety
of approaches, including a noninvasive assay for
following fat mass reconstitution in vivo, to identify a
subpopulation of early adipocyte progenitor cells
(Lin:CD29+:CD34+:Sca-1+:CD24+) resident in adult
WAT. When injected into the residual fat pads of
A-Zip lipodystrophic mice, these cells reconstitute
a normal WAT depot and rescue the diabetic pheno-
type that develops in these animals. This report
provides the identification of an undifferentiated
adipocyte precursor subpopulation resident within
the adipose tissue stroma that is capable of prolifer-
ating and differentiating into an adipose depot in vivo.
INTRODUCTION
Obesity, the excessive accumulation of white adipose tissue
(WAT), is a highly prevalent condition that results from an imbal-
ance of energy expenditure versus food intake, leading to an
increase in the storage of energy in the form of lipid within
WAT (Rosen and Spiegelman, 2006). Obesity is associated with
increased risk of type II diabetes, hyperlipidemia, hypertension,
and certain types of cancer, causing a major public health prob-
lem (Kopelman, 2000). Despite the clinical importance of obesity,
our understandingWAT development in vivo is extremely limited.
The increase in adipose mass in obesity is the result of both
hypertrophy, an increase in adipocyte size, and hyperplasia, an
increase in cell number (Hirsch and Batchelor, 1976; Lane and
Tang, 2005). Since mature adipocytes are postmitotic (Simon,
1965), adipocyte hyperplasia in adults requires that new adipo-
cytes be produced from the differentiation of precursor cells.
However, the identity of the precursor cells in vivo is unknown
(Gesta et al., 2007), and the cellular and molecular mechanisms
regulating adipogenesis in vivo are poorly understood.240 Cell 135, 240–249, October 17, 2008 ª2008 Elsevier Inc.In vitro studies using well-characterized preadipocyte cell
lines have elucidated a transcriptional cascade that is required
for adipogenesis, involving the sequential induction of a series
of transcription factors, including Krox20, Klf4, C/EBPd, C/EBPb,
C/EBPa, and PPARg, that leads to the formation of differenti-
ated, lipid-laden adipocytes (Birsoy et al., 2008a; Gonzalez,
2005). Experiments studying the ability of preadipocyte cell lines
to differentiate into adipocytes have shown that these cell lines
have a limited ability to differentiate in vivo (Fischbach et al.,
2004; Mandrup et al., 1997). Previous reports have also shown
that cells derived from the WAT stromal-vascular fraction (SVF)
from mice and humans can differentiate into several lineages,
including adipocytes, in primary cell culture (Zheng et al., 2006;
Zuk et al., 2001), and these multipotent cells have been named
adipocyte-derived stem cells (ADSCs). However, the capacity
of ADSCs and primary preadipocytes to differentiate into adipo-
cytes in vivo is limited (Hemmrich et al., 2005; Hong et al., 2006;
Patrick et al., 1999; Sengenes et al., 2005). Thus, the identity of
the in vivo adipocyte precursor cells is unknown.
Here, we report the use of fluorescence-activated cell sorting
(FACS) in combination with a functional in vivo transplantation
scheme to identify early adipocyte precursor cells resident in
the WAT vascular stroma. Analogous assays employing precur-
sor cell transplantation in vivo have previously been developed
for the study of hematopoietic, mammary epithelial, and sper-
matogonial stem cells (Brinster and Zimmermann, 1994; Deome
et al., 1959; Ford et al., 1956; Shackleton et al., 2006; Spangrude
et al., 1988). We assayed the adipogenic potential of different
stromal cell populations in A-Zip lipodystrophic transgenic mice,
which have a generalized lack of adipose tissue, and show that
the residual WAT depots of A-Zip mice can provide a microenvi-
ronment that supports proliferation and differentiation of adipose
tissue from a small subpopulation of cells isolated fromwild-type
WAT stroma.
RESULTS
FACS Isolation of AdipogenicCells Expressing StemCell
Markers in the Stroma of White Adipose Tissue
WAT is composed of multiple cell types, including adipocytes,
vascular cells, and populations of fibroblast like cells, that have
not been well characterized (Cinti, 2005). So that potential adipo-
cyte progenitor cells could be identified, the SVF of wild-type
WAT was fractionated (Rodbell, 1964) and FACS was performed
for the isolation of distinct cell populations on the basis of the
differential expression of previously characterized cell-surface
markers expressed by stem cell populations in other tissues.
Populations of individual cells were first sorted on the basis of
their expression of CD29 (b1-integrin) and CD34, both of which
are expressed by several stem cell populations (Shackleton
et al., 2006; Trempus et al., 2003; Wilson et al., 2007). Four pop-
ulations were isolated: CD29:CD34 (P1), CD29lo:CD34 (P2),
CD29lo:CD34+ (P3), and CD29hi:CD34+ (P4). Sorted cells were
plated and grown to confluence, and the adipogenic potential
of these sorted populations (P1–P4) was analyzed in vitro by oil
red O staining. The induction of adipocyte differentiation was
tested through the use of a standard protocol for adipogenesis
that employs a cocktail of insulin, glucocorticoids, and isobutyl-
methylxanthine (IBMX) (see the Experimental Procedures). Only
the P3 fraction of CD29hi:CD34+ cells showed significant differ-
entiation in vitro, with accumulation of cells displaying unilocular
lipid droplets (Figure S1 available online).
Having established that there was a subpopulation of cells in
adipose stroma that was capable of differentiating into adipo-
cytes in vitro, we next performed FACS for additional cell surface
to further purify the adipogenic subpopulations. The strategy
that was used in these studies is shown (see Figure 1) and
described below. First, endothelial cells and hematopoietic cells
were depleted from the SVF on the basis of staining of CD31,
CD45, and Ter119, generating a lineage-negative (Lin) popula-
tion. This step removed 25% of the cells in the SVF. Second,
the cell populations depleted of the lineage markers were sepa-
rated on the basis of staining for CD34 and CD29, as described
above. The Lin:CD34+:CD29+ subpopulation was further sepa-
rated on the basis of staining for stem cell antigen 1 (Sca-1) and
CD24 (Figure 1 and Figure 2A), two cell-surface proteins that are
expressed on stem cell populations from other tissues (Shackle-
ton et al., 2006; Spangrude et al., 1988; Wilson et al., 2007).
The Lin:CD29+:CD34+:Sca-1+ (Sca-1+) population comprises
approximately half of the cells present in the SVF (53.5%), but
only a small population of cells also expressed CD24 with the
total number of Lin:CD29+:CD34+:Sca-1+:CD24+ (CD24+) cells
constituting in total0.08% of the cells in the SVF (see Figure 1).
The Sca-1+ population was negative for CD105 (endoglin) and
CD117 (c-kit) (data not shown), distinguishing these cells from
bone marrow-derived mesenchymal stem cells and hematopoi-
etic stem cells (Li and Johnson, 1995; Sun et al., 2003).
We next tested whether the CD24+, Lin:CD29+:CD34+:
Sca-1+:CD24 (CD24) and Lin:CD29+:CD34 (CD34)
subpopulations can differentiate into adipocytes in vitro via the
aforementioned protocol. We found that after exposure to an
adipogenic cocktail in vitro, both the CD24+ and CD24 popula-
tions developed into adipocytes with large, unilocular lipid
droplets that stain with oil red O (Figure 2B). Similar levels of dif-
ferentiation of both the CD24+ and CD24 subpopulations were
also observed when insulin alone was substituted for the full adi-
pogenic hormone cocktail (data not shown). RT-PCR analysis of
mRNAs derived from these differentiated adipocytes showed an
approximately 7-fold increase in the expression of aP2 in both
the CD24+ and CD24 cultures versus the undifferentiated
populations. Expression of Adipsin was increased 5-fold in the
CD24 population and 25-fold in the CD24+ population(Figure 2C). The 5-fold greater induction of Adipsin expression
in the CD24+ versus CD24 adipocytes suggested that these
are functionally distinct populations (confirmed in vivo, see
below). Although both CD24 and CD24+ populations could
robustly differentiate into adipocytes, the CD34 cells failed to
differentiate in response to the same adipogenic cocktail. Fur-
ther experiments showed that the CD24 and CD24+ cell popu-
lations are also capable of differentiating into bone, cartilage,
and muscle in vitro (Figure S2). In addition, although the unfrac-
tionated SVF showed some ability to differentiate into adipo-
cytes, it did so poorly when compared to the CD24 and
CD24+ populations, displaying significantly smaller numbers of
oil red O positive cells with multilocular lipid accumulation
(Figure 2B) and lower levels of Adipsin and aP2 expression
(Figure 2C). The finding that the SVF is poorly adipogenic in com-
parison to the CD24 population, which represents 53.5% of the
SVF, suggested that there may be inhibitory factors present in
the unfractionated SVF. Quantification of the number of oil red
O-positive cells derived from each cultured cell population iso-
lated in the FACS sorting scheme revealed that the CD24 and
CD24+ were 24-fold and 19-fold enriched, respectively, for adi-
pocytes versus the unfractionated SVF (Table S1). The extent
of differentiation of the SVF in these experiments was similar to
that documented in previous studies (Boquest et al., 2005; Izad-
panah et al., 2006; Wagner et al., 2005). These data indicated
that the FACS strategy that was employed enriched for adipo-
cyte precursor cells.
Markers of Adipogenesis Are Induced in Lipodystrophic
White Adipose Tissue
We next tested whether the different stromal cell fractions could
reconstitute WAT in vivo by transplanting 50,000 donor cells
into recipient animals. However, we did not observe any differen-
tiation of either the CD24+ or CD24 subpopulation into
adipocytes after injection of 50,000 cells into adipose tissue
of wild-type mice. This suggested that the microenvironment
Figure 1. A Schematic Representation of the FACS Strategy
The scheme for the FACS analysis is shown as a dendrogram of the hierarchy
developed for cell sorting. The percentage yield of each population compared
to the starting number live single cells derived from the SVF is indicated. Re-
sults are shown as mean ± SD (n = 4).Cell 135, 240–249, October 17, 2008 ª2008 Elsevier Inc. 241
Figure 2. Identification of Adipogenic Cell
Populations in Adipose Stroma
(A) Dot plots showing FACS staining profiles
and gating (black boxes) of adipose SVF from
8-week-old wild-type mice. The live, PI-negative
singlets were sorted for lack of CD31 and Ter119
expression (left-hand plot) and were further sepa-
rated on the basis of expression of CD45 (second
plot from the left). CD45 cells (Lin) were then
sorted on the basis of expression of CD34 and
CD29 (second plot from the right). CD34 cells
were collected for analysis, and the CD34+ cells
were sorted on the basis of staining for Sca-1
and CD24 (right-hand plot). Representative
CD24 and CD24+ gates used for sorting are indi-
cated.
(B) The sorted CD24+, CD24, and CD34 cells
and unsorted SVF were cultured and induced to
differentiate with IBMX, glucocorticoid, and insu-
lin. The cells were then cultured for 12 days prior
to staining with oil red O. Macroscopic (upper
panel) and microscopic (lower panel) views of the
oil red O-stained dishes are shown (upper panel).
(C) RNA was isolated from cells differentiated for
12 days, and Taqman RT-PCR analysis was per-
formed for the adipocyte markers Adipsin and
aP2 on the indicated populations: CD24+, CD24,
CD34, and unsorted SVF. Results are shown as
mean ± SEM for each population (n = 3). *,
p < 0.05 between CD24+ and CD24 versus
CD34 and SVF. #, p < 0.05 between CD24+
versus CD24.of an adult adipose depot might not be conducive for the prolif-
eration and differentiation of adipocyte precursor cells.
We next considered the possibility that A-Zip lipodystrophic
mice could support adipogenesis after injection of the precursor
cells capable of differentiating into adipocytes in vitro. A-Zip
mice express a dominant-negative transcription factor (A-Zip),
which inhibits C/EBP transcription factors, under the control of
the aP2 promoter (Moitra et al., 1998). Since aP2 is expressed
relatively late in adipogenesis, we reasoned that there might be
an expansion of precursor cells upstream of the block in differen-
tiation caused by the expression of the transgene.
Consistent with this hypothesis, A-Zip mice, which have a se-
vere, generalized lack ofWAT (Moitra et al., 1998), do retain small
WAT depots discernable at the sites where mature WAT depots
typically develop in wild-type animals (Figure 3A). Despite the
paucity of adipocytes in A-Zip WAT, these small depots do con-
tain a limited number of lipid-filled cells that are similar in size to
wild-type adipocytes (Figure 3B), suggesting that some cells
may escape the block in adipogenesis caused by A-Zip expres-
sion. There is also a marked increase in the number of stromal
cells present in A-Zip WAT, and approximately half of this ex-
panded cell population expresses the preadipocyte marker
Pref-1 (Figures 3B and 3E).
We hypothesized that inhibition of the formation of mature
adipocytes in the WAT depots of the A-Zip animals would lead242 Cell 135, 240–249, October 17, 2008 ª2008 Elsevier Inc.to an increase of proliferation and differentiation of precursor
cells upstream of the block in differentiation. If true, cells in the
stromal fraction of these depots should continue to express
genes induced early during adipogenesis (upstream of the block
induced by the transgene) and continually proliferate in amanner
similar to the clonal expansion phase of adipogenesis in preadi-
pocyte cells lines induced to differentiate in vitro. To test
this possibility, we analyzed the expression of genes typically
induced early during adipogenesis in vitro in the A-Zip WAT
depots. We found that the RNA levels for the early markers of
adipogenesis, Klf4, Krox20, and C/EBPd, were increased in
A-Zip WAT depots relative to wild-type WAT by 191%, 498%,
and 291%, respectively, whereas the expression of PPARg,
a marker of mature adipocytes, was decreased to 56% of the
levels in wild-type tissue (Figure 3C). Immunohistochemistry for
the preadipocyte marker Pref-1 demonstrates both the presence
of preadipocytes in wild-type WAT and an increase in Pref-1-
positive cells in lipodystrophic WAT (Figures 3B and 3E).
Immunohistochemistry for Krox20 and Klf4 indicated very low
expression of these factors at the protein level in wild-type
WAT (Figures 3D and 3E), with a significant increase in the num-
bers of Klf4- and Krox20-positive cells in A-Zip WAT (Figures 3D
and 3E). In lipodystrophic WAT, there was also a similar increase
in the level of CREB phosphorylation, one of the earliest events
observed during adipogenesis in vitro (Zhang et al., 2004).
During adipogenesis in vitro, preadipocytes proliferate during
a stage of clonal expansion (Bernlohr et al., 1985) that coincides
with the expression of the aforementioned transcription factors.
To test whether proliferation is also increased in lipodystrophic
WAT, we treated A-Zip mice with BrdU for 7 days. Analysis of
Figure 3. A-Zip Lipodystrophic Adipose Tissue Provides an Adipo-
genic Microenvironment
(A) Ventral view of the lower abdomen of female littermate wild-type (WT) and
A-Zip mice at 12 weeks of age. The bladder (bl), uterus and fallopian tubes (ut),
and parametrial WAT (adi) are indicated.
(B) Results from immunohistochemistry for Pref-1 in WT and A-Zip mice are
shown.
(C) Taqman RT-PCR was performed for the markers of early adipogenesis,
Krox20, Klf4, and Cebpd, as well as PPARg. RNA was isolated from adult
A-Zip and WT parametrial adipose tissue. Results are shown as mean ±
SEM, n = 3 (*, p < 0.05; **, p < 0.001).
(D) Immunostaining of parametrial WAT from A-Zip and WT mice for the early
markers of adipogenesis Krox20, Klf4, and phospho-CREB, as well as the
proliferation marker BrdU, is shown. For BrdU incorporation analysis, mice
were treated with BrdU for 7 days prior to immunostaining.
(E) Quantification of the immunostaining results shown as the percent of cells
positive for the indicated immunohistochemical marker. Data are shown as
mean ± SEM. n = 125–614 cells (*, p < 0.05; **, p < 0.001).
(F) Flow cytometry analysis of BrdU incorporation. Wild-type (WT), A-Zip, and
an A-Zip isotype control (Neg) are shown for both the Sca-1+ adipogenic cell
population (left panel) and the Lin+ population (right panel), demonstrating
the proliferative nature of the Sca-1+ cells from lipodystrophic mice.BrdU incorporation demonstrated that A-Zip adipose tissue con-
tains large numbers of proliferating cells compared to wild-type
adipose, in which there are low levels of BrdU incorporation
(Figures 3D and 3E). Flow cytometry demonstrated that the cells
from A-Zip mice that incorporated BrdU overlapped substan-
tially with the adipogenic Sca-1+ cell subpopulation (which
includes both the CD24+ and CD24 subpopulations) that we
showed are capable of robustly differentiating into adipose
tissue in vitro. In contrast, the Sca-1+ population from wild-type
animals did not incorporate BrdU (Figure 3F). The increase in
BrdU incorporation in A-Zip mice is almost exclusively due to
proliferation of the Sca-1+ population because BrdU incorpora-
tion into the Lin+ population was not different between cell
populations derived from wild-type and A-Zip WAT (Figure 3F).
Of note, the number of CD24+ cells is increased 277% in A-Zip
WAT (Figure S3).
Reconstitution of Functional White Adipose Tissue
In Vivo
These data suggested that the adipose tissue depot of lipody-
strophic mice might provide a microenvironment, or niche,
capable of supporting the proliferation and differentiation of
adipocyte precursor cells. We next tested whether the FACS-
sorted subpopulations could develop into adipose tissue when
injected into the WAT depots of A-Zip mice. We used cells
derived from ubiquitin-GFP mice, which express GFP ubiqui-
tously, as donors in transplantation experiments in which a total
of 50,000 freshly purified cells from the CD24+, CD24, or CD34
subpopulations were injected unilaterally into the parametrial
WAT depot of A-Zip recipients.
Inspection of the injected depots 12 weeks after injection
revealed that injection of CD24+ donor cells developed into a
normal-sized WAT depot at the site of injection (Figure 4A).
Reconstitution of the injected parametrial fat pad was seen in
11 out of 20 animals that received the injection of CD24+ donor
cells, which is comparable to the success rates achieved in
similar grafting experiments from mammary gland (80%) and
testis (18%–37%) (Brinster and Zimmermann, 1994; Smith and
Medina, 1988). The depots that develop after injection of
50,000 CD24+ cells were composed almost entirely of GFP-pos-
itive (GFP+) cells with the unilocular morphology characteristic of
mature white adipocytes (Figure 4B), confirming that the adipose
depot that developed was derived from the donor cells. In fact,
the reconstituted WAT appeared to be identical to the ubiqui-
tin-GFP donor WAT with the exception of the vasculature, which
was GFP+ in the donor WAT but GFP-negative in the reconsti-
tuted tissue (Figure 4B). To further investigate the contribution
of the CD24+ cells to other cell populations within the reconsti-
tuted WAT, we analyzed cell subpopulations for GFP expression
by FACS. Although GFP+ donor cells remained present in the
CD24+ population in the reconstituted WAT (15.6% ± 1.3%),
GFP was not detected in the endothelial (CD31+) or hematopoi-
etic populations (CD45+) (Figure 4C), indicating that the CD24+
cells populations do not contribute to these lineages in the
reconstituted WAT depots.
Injection of the unfractionated SVF resulted in a low success
rate of WAT reconstitution (1 of 10 recipients), and the Lin:
CD34+ population, which also contains the CD24+ population,Cell 135, 240–249, October 17, 2008 ª2008 Elsevier Inc. 243
also failed to reconstitute WAT (zero of six injections), indicating
that the CD24+ population is highly enriched for adipogenic pre-
cursor cells. The CD24 (zero of ten recipients) and CD34 (zero
of six recipients) populations also failed to reconstituteWAT after
injection into A-Zip mice. Small numbers of GFP+ cells were de-
tectable in adipose depots injectedwith the CD24 cells, indicat-
ing that these cells were able to engraft in WAT. However, in this
Figure 4. The CD24+ Cell Population Develops into Functional White
Adipose Tissue
(A) Cells sorted from theCD24+,CD24, orCD34 populationswere injected into
parametrial adipose tissue pads of A-Zip mice. The fat pads were removed from
these animals and an uninjected A-Zip control and were compared to a wild-
type (WT) parametrial fat pad (bottom image). The scale bar represents 1 cm.
(B) Whole-mount fluorescent imaging for GFP is shown for A-Zip fat pads that
were injectedwith CD24+, CD24, andCD34 cells withWT and ubiquitin-GFP
donor WAT (UbcGFP) controls. The scale bar represents 100 mM.
(C) FACS analysis of GFP expression in the SVF of reconstituted WAT.
Histograms are shown for different SVF subpopulations, as indicated:
CD24+, CD24 Ter119:CD31+ (CD31+), and Ter119:CD45+ (CD45+).
(D) Plasma (glucose) from A-Zip mice injected with the CD24+, CD24, CD34,
or SVF cells, as well as WT and A-Zip controls. Results are shown as mean ±
SEM. Correction of blood glucose by the CD24+ population is significant
(p < 0.05) at week 2 and remains significant through the 12 week experimental
endpoint (n = 5). Results are shown as mean ± SEM.
(E) The plasma (insulin) at the 12-week endpoint of A-Zip mice that were
injected with the CD24+, CD24, or CD34 cell populations and noninjected
wild-type and A-Zip controls is shown. Results are shown as mean ± SEM;
*, p < 0.05 (n = 5).244 Cell 135, 240–249, October 17, 2008 ª2008 Elsevier Inc.case, GFP+ lipid-filled cells were not detected, suggesting that
these cells have a limited ability to differentiate. Overall, these
studies showed that the CD24+ cells were the only subpopula-
tion of the SVF capable of forming an adipose tissue depot.
(See Table S2 for a summary of the fate of all of the injected
cell populations.) As mentioned previously, injection of the
CD24+ population into wild-type fat pads did not lead to the ap-
pearance of GFP-labeled adipocytes, suggesting that the micro-
environment of the A-Zip adipose depot is necessary for the
differentiation of the precursor cells (data not shown).
We next tested whether the adipose depots that formed in
diabetic A-Zip mice after injection of 50,000 CD24+ donor cells
were functional. Plasma glucose and insulin levels in A-Zip
mice injected with the CD24+, CD24, or CD34 cell populations
were compared to noninjected A-Zip and wild-type control ani-
mals. Blood glucose was normalized after injection of the
CD24+ population into the A-Zip animals in those animals where
an adipose depot had formed (Figure 4D). None of the other cell
populations showed this capacity. The decrease of blood
glucose levels was significant within 2 weeks of injection and
was sustained for 12 weeks, at which point the animals were
sacrificed and the adipose depot was analyzed for assessment
of whether the precursor cells had engrafted. Plasma insulin
levels were also normalized in these CD24+-injected animals
(Figure 4E). In addition, the plasma levels of adiponectin, a
hormone that is secreted specifically from mature adipocytes
(Hu et al., 1996), is also increased in the mice that display recon-
stituted WAT versus the baseline levels of A-Zip controls
(10.2-fold, p < 0.05) (Figure S4). These data indicate that the
CD24+ cells generate functional WAT when injected into the
parametrial WAT depot of A-Zip mice.
One limitation of these experiments is that the formation of an
adipose depot could not be assessed until the 12 week experi-
ment had been completed. In order to monitor the ability of the
CD24+ cells to develop into adipocytes prior to necropsy, we
made use of bacterial artificial chromosome (BAC) transgenic
mice expressing luciferase under control of the leptin promoter
(Birsoy et al., 2008b). The expression of luciferase in these mice
is restricted to adipose tissue (Figure 5A) and to mature adipo-
cytes within adipose tissue (Figure 5B). Luciferase activity can
be followed noninvasively in vivo by imaging with a CCD camera.
Since cells of the SVF do not express the luciferase reporter
(Figure 5B), the transplant of donor cells from the leptin-lucifer-
ase BAC transgenic mice allows us to follow the development
of mature adipocytes (as marked by luciferase activity) from
the donor cells noninvasively in vivo.
SVF cells were isolated from leptin-luciferasemice, purified by
FACS via the protocol described above, and injected in the fat
depots of A-Zip mice. Mice injected with the CD24+ cell popula-
tion derived from leptin-luciferase animals expressed luciferase
in the injected depot beginning at 2 weeks after injection (in three
of six injected animals) with the expression of luciferase gradu-
ally increasing through the end of the 12 week time course
(Figure 5C). In contrast, injection of the control CD34 cells,
which do not differentiate in vitro (Figure 2B), did not yield detect-
able luciferase expression (Figure 5C). Transplantation of the
CD24 population, which shows adipogenic potential in vitro,
showed extremely low levels of luciferase expression in the
Figure 5. Imaging of Adipocyte Differentiation In Vivo
(A and B) Luciferase activity in tissues and fractionated WAT isolated from
leptin-luciferase mice. The indicated tissues were isolated, and luciferase
activity was determined. Data shown are normalized to total protein in each
lysate. Results are shown as mean ± SEM; ***, p < 0.001 (n = 3).
(C) Luciferase imaging of adipocyte differentiation in the A-Zip transplantation
model at indicated time points after injection of 50,000 donor cells from the
CD24+, CD24 , or CD34 cell populations.
(D) Luciferase imaging of adipocyte differentiation in wild-type mice fed a high-
fat diet. Wild-type mice were injected with the indicated cell populations,
CD24+, CD24, CD34, or SVF, allowed to recover for 2 weeks, and then
treatedwith high-fat diet for 6 weeks prior to luciferase imaging. Luciferase sig-
nal was detected in three of eight animals injected with the CD24+ population
not detected in the CD24, CD34, or unfractionated SVF injected animals
(zero of five for each population). A magnified image of the luciferase signal
from the CD24+ image is shown below the panel (blue border). The color
bars indicate photon counts relative to pseudocolor for the adjacent panels
images.
(E) Quantitation of luciferase activity from HFD-fed mice injected with FACS-
sorted cell populations. Luciferase activity is significantly increased after
injection of the CD24+ cells versus the levels in animals receiving the graftsinjected adipose depot after 1 month. This result suggested that
the CD24 subpopulation might be capable of adipogenesis
in vivo but that the differentiation or proliferative potential of
these cells is limited. This observation is consistent with finding
that the CD24 population was unable to correct blood glucose
levels in the lipodystrophic mice (Figure 4D). None of the cell
populations, including the CD24+ cell population, expressed
luciferase after injection into WAT of wild-type mice at any point
in a 12 week time course (data not shown).
We next tested the fate of leptin-luciferase-derived FACS-
sorted cells after injection into wild-type mice fed a high-fat
diet (HFD). After injection of 50,000 CD24+ cells into the fat pad
of high-fat fed mice, there was clearly evident luciferase activity
in three of eight injected animals, a frequency consistent with
that seen after injection of precursor cells into lipodystrophic
mice (Figures 5D and 5E). In contrast, we failed to detect lucifer-
ase activity in any of the five animals that received injections of
an equivalent number of CD24, CD34, or SVF cells (Figures
5D and 5E). Although significant, the luciferase signal after injec-
tion of the CD24+ cells was lower than that seen after injection of
precursor cells into the A-Zip mice. Overall, these data indicate
that the CD24+ cell population also has the unique ability to dif-
ferentiate into adipocytes in the context of diet-induced obesity
as compared to the other stromal cell populations.
DISCUSSION
Obesity is associated with an increased adipocyte number
(Faust et al., 1978;Wise, 1975). In addition, a recent study follow-
ing C14 levels in WAT has confirmed that the adipocytes contin-
uously turn over in adult humans (Spalding et al., 2008). These
findings, coupled with the knowledge that mature adipocytes
are postmitotic, strongly suggest that there is an adipose tissue
precursor cell population resident in adipose tissue. However,
studies of the regulation of WAT mass in vivo have been limited
by the fact that physiologic adipocyte precursor cells have not
been identified. As a consequence, our understanding of the
developmental pathways by which adipose tissue forms and
the mechanisms controlling the regulation of adipocyte number
in vivo is limited.
In this report, we use FACS in combination with an assay for
monitoring adipogenesis in vivo to identify a small subpopulation
of CD24+ cells in the adipose tissue stroma (0.08% of total
cells) that is capable of forming a normal-size fat depot in vivo
and complementing the diabetic phenotype of lipodystrophic
mice. These studies demonstrate that primary cells from the ad-
ipose tissue stromal fraction can proliferate and differentiate into
functional, mature adipocytes to reconstitute a fully functional
adipose depot in vivo. Precursor cells resident in WAT that are
capable of reconstituting an adipose depot in vivo have not
been previously identified. Immunohistochemical localization of
CD24 in WAT demonstrated that CD24+ cells are located peri-
vascularly within WAT (data not shown), consistent with previous
reports of the localization of putative adipocyte precursors (Cinti
et al., 1984; Wassermann, 1926), a conclusion that has recently
of other three stromal cell populations. Results are shown as mean ± SD; *,
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been confirmed in vivo with PPARg-reporter mice (Tang et al.,
2008). The identification of these CD24+ cells as adipocyte pro-
genitors that are capable of adipogenesis in vivo now provides
a potential means for identifying the cellular and molecular
mechanisms regulating adipocyte number in vivo.
Although previous studies have shown that adipose tissue
stromal cells can differentiate in vitro after several passages
(Boquest et al., 2005; Izadpanah et al., 2006; Lee et al., 2004;
Wagner et al., 2005), cells isolated in this manner were only able
to produce fat pads in vivo when they were seeded into artificial
scaffolds in vitro and induced to differentiate in culture, prior to
implantation (Hemmrich et al., 2005; Patrick et al., 1999). In
addition, the capacity of these cells to restore adipose tissue
function was not assessed.
As an alternative, we employed FACS to separate cell popula-
tions from freshly isolated wild-type SVF on the basis of expres-
sion of a variety of well-characterized stem cell markers. This
approach enabled us to identify two subpopulations of cells in
wild-type WAT SVF with adipogenic potential in vitro (Figure 2).
Previous studies have shown that cells derived from WAT SVF
are capable of differentiation into multiple cell lineages, including
adipocytes (Boquest et al., 2005; Izadpanah et al., 2006; Lee
et al., 2004; Wagner et al., 2005). However, in numerous exper-
iments, including ours, the differentiation of unfractionated SVF
into adipocytes in vitro is limited with only a small percentage
of cells showing multilocular lipid accumulation (Figure 2B).
The CD24+ and CD24 stromal subpopulations reported here
both display robust adipogenesis in cell culture, with themajority
of cells not only accumulating lipid but also developing a uniloc-
ular morphology with the induction of gene expression associ-
ated with mature adipocytes in vivo (Figures 2B and 2C). These
results indicate that we have identified two subpopulations of
WAT SVF that may be significantly enriched for adipocyte
precursor cells compared to the unfractionated stromal fraction.
Of note, the adipogenic CD24 population comprises approxi-
mately half of the unfractionated SVF, which differentiates
poorly, suggesting that there may be inhibitors present in the
SVF that are removed by purification of the Sca-1+ cell popula-
tions. It is possible that the CD24 population is comprised of
preadipocytes, a possibility supported by the expression of
Pref-1 in these cells (data not shown). Also consistent with this
hypothesis, luciferase expression indicated that the CD24 cells
are capable of limited differentiation into adipocytes in vivo
(Figure 5C), but they are unable to develop into a full-sized depot
(Figure 4A).
To test the adipogenic potential of the SVF subpopulations
identified in our studies in vivo, we developed a functional assay
using A-Zip lipodystrophic mice as recipients. The use of A-Zip
mice for these studies is important because they have a paucity
of mature, functionally competent adipocytes (Moitra et al.,
1998). In addition, WAT of A-Zip animals showed increased
expression of early markers of adipocyte differentiation and
high rates of proliferation, suggesting that it provides a niche
conducive for promoting early events in adipogenesis (Figure 3).
Indeed, we only observed adipose tissue development after
injection of CD24+ donor cells into A-Zip mice or HFD-fed ani-
mals. In contrast, we did not observe the development mature
adipocytes after injection of an equivalent number of CD24+246 Cell 135, 240–249, October 17, 2008 ª2008 Elsevier Inc.donor cells into the WAT of wild-type animals at weaning (data
not shown). This result was not unexpected because, in contrast
to the high rates of proliferation and differentiation in hematopoi-
etic, epithelial, and spermatogonial stem cells previously used in
analogous cell transplant studies (Bryder et al., 2006; Fata et al.,
2001; Thayer et al., 2001), WAT in adult rodents displays only low
levels of cell proliferation and new adipocyte formation (Green-
wood and Hirsch, 1974).
As mentioned above, CD24+ cells transplanted into mice fed
a high-fat diet can also differentiate into adipocytes with the
appearance of a significant level of luciferase activity 6 weeks
after injection. None of the other stromal cell populations show
luciferase activity after injection into the HFD-fed animals, show-
ing that, as was also the case for transplants into lipodystrophic
mice, the CD24+ cells have unique developmental potential
among the different populations in the adipose tissue SVF. How-
ever, in these experiments, the luciferase signal is significantly
lower than that seen in the CD24+-injected A-Zip animals (Fig-
ure 5). The lower signal in the HFD transplant study is likely
due to a combination of factors, including competition between
larger numbers of resident nonluciferase CD24+ cells present
within the wild-type adipose depot and the considerably smaller
expansion of the adipose depot after transplantation into HFD
mice as compared to the complete reconstitution of an adipose
depot after injection of CD24+ cells into a lipodystrophic adipose
depot. The more limited contribution of the transplanted CD24+
cells to the adipose depot in a wild-type setting is consistent with
analogous studies of progenitor cells from other systems, such
as the hematopoietic, spermatagonial, and mammary epithelial
cells, where, in general, the native cell populations need to be
ablated prior to transplantation in order for the transplanted cells
to robustly repopulate the organ (Brinster and Zimmermann,
1994; Deome et al., 1959; Ford et al., 1956; Shackleton et al.,
2006; Spangrude et al., 1988). The demonstration that theCD24+
can contribute to the adipose depot after high-fat feeding but not
in chow-fed animals suggests that the high-fat diet may create
a state in which inductive factors promote adipocyte develop-
ment, a possibility that is consistent with an increase in adipo-
cyte number in adipose tissue after high-fat feeding (Johnson
et al., 1971; Lemonnier, 1970, 1972).
The lack of normal mature adipose tissue in lipodystrophic
animals leads to diabetes, also permitting a determination of
the functional competence of the transplanted adipose tissue
precursors. It has previously been shown that the transplant of
900 mg of normal adult WAT into A-Zip mice is required for cor-
rection of their insulin resistance and hyperglycemia (Gavrilova
et al., 2000) and that transplants of smaller amounts of adipose
tissue failed to correct diabetes in these animals. However, in
our experiments, injection of only 50,000 CD24+ cells was capa-
ble of reconstituting a normal-sized WAT depot and correcting
the diabetes of a lipodystrophic animal. This is several logs lower
than the number of cells required for correction of the diabetic
phenotype after transplant of mature adipose tissue (Gavrilova
et al., 2000) or that are present in the fully formed adipose depots
that develop from these cells. These results strongly suggest that
the CD24+ donor cells proliferate prior to differentiating into
mature adipocytes, suggesting that adipocyte progenitors with
proliferative capacity are resident in the adult WAT SVF fraction.
Injections of 3H or BrdU into wild-type animals failed to label ad-
ipose tissue in previous studies, indicating that the proliferative
potential of adult adipose tissue might be limited (Greenwood
and Hirsch, 1974). Our finding that a subpopulation of SVF cells
is able to proliferate to form a mature fat pad in A-Zip mice and
contribute to adipocytes upon HFD treatment, along with recent
findings that human adipose tissue turns over at a low rate
(Spalding et al., 2008), suggests that cells resident in WAT do
have significant proliferative capacity in vivo but that the prolifer-
ation and differentiation of these cells is tightly regulated in
normal animals.
The lack of differentiation of any of the cell subpopulations
upon injection into wild-type WAT suggests that the niche pro-
vided by A-Zip mice is critical for the expansion and differen-
tiation of adipocyte progenitors. This possibility is consistent
with the observation that intravenous injections of the CD24+
cells into A-Zip mice did not result in the restoration of adipose
tissue mass, luciferase expression, or correction of blood glu-
cose levels (data not shown), indicating that these cells can
not ‘‘home’’ to the adipose tissue in lipodystrophic mice. It is
possible that the ability of lipodystrophic adipose tissue to
support the proliferation and differentiation of precursor cells
is at least partially the result of a loss of feedback inhibition
of precursor cells by fully differentiated adipocytes. The obser-
vation that CD24+ cells do not contribute to adipocyte popula-
tions after injection into wild-type WAT is also consistent with
the possibility that the there may be inhibitory cell types and/or
factors in normal adult adipose tissue. The nature of this inhib-
itory factor or cell type is unknown and is currently under
investigation.
The identification of the CD24+ cell subpopulation of adipose
SVF as physiologic adipocyte precursors capable of producing
functional WAT in vivo also provides a potential means for recon-
stitution of adipose depots in patients with lipodystrophy. For
example, one could isolate an analogous cell population from
human adipose depots as a source of donor cells for patients.
Alternatively, since in many cases the genetic defect causing lip-
odystrophy is known, one could perform autologous transplants
by isolating the adipose progenitor cells from affected patients
and correcting the genetic defect ex vivo. Although the approach
reported here for mice could be adapted to include other
species, much additional investigation would be necessary for
assessment of the potential of this approach for humans. Addi-
tionally, the finding that both the CD24 and CD24+ cell popula-
tions are capable of differentiating into bone, cartilage, and
muscle (Figure S2) suggests that these populations might also
prove useful for the generation of other mesenchymal tissues.
The identification of an adipocyte precursor cell population
provides a means for identifying tissue factors in wild-type and
lipodystrophic WAT that regulate adipocyte proliferation and dif-
ferentiation. Furthermore, the availability of the leptin-luciferase
mice as donors in the A-Zip transplant assay, which allows the
noninvasive monitoring of adipogenesis in vivo, should facilitate
the identification of conditions that optimize engraftment of
adipose tissue precursors. Overall, this approach will provide
a means by which researchers can study the potential of cells
from various sources to form WAT and creates new possibilities
for the determination of the roles that individual factors play in thecontrol and maintenance of WAT mass in vivo in a variety of
nutritional states, including obesity.
EXPERIMENTAL PROCEDURES
Mice
FVBN/J ubiquitin-GFP mice were obtained from the Jackson Laboratory (Bar
Harbor, ME). A-Zip mice have been described previously (Moitra et al., 1998)
and were maintained by crossing of A-Zip male to FVBN/J female mice
(Jackson Laboratory). The leptin-luciferase transgenic mice, originally gener-
ated in the C57Bl/6 mouse strain (Birsoy et al., 2008b), were reproduced bymi-
croinjection in the FVBJ/N, ensuring that donor cells would be isogenic to the
recipient A-Zip mice. The specifics of the leptin-luciferase BAC used to make
the FVB transgenic mice are as follows. The modified BAC contains 22 kb of
50 sequence and 150 kb of 30 sequence relative to the Leptin transcription
start site, with the coding sequence of firefly luciferase inserted in the transla-
tion start site of Leptin. All animals were housed on a 12 hr light/dark cycle at
23C with free access to water and food. All procedures were in accordance
with the guidelines of The Rockefeller University Laboratory Animal Research
Center. For high-fat-diet treatment, mice were fed 60% kcal fat rodent food
(Research Diets, New Brunswick, NJ).
Antibodies
Antibodies were purchased from eBioscience unless otherwise stated,
including the following: CD34-Alexa700, CD45-FITC, CD45-PE-Cy7, Terr-
119-APC-Alexa750, CD31-PE-Cy7, CD24-PE, CD29-APC and Sca-1-Pacific
Blue (Biolegend), Klf4 and Krox20 (Santa Cruz Biotech.), Pref1 (MLB),
phospho-CREB (Cell Signaling Technologies), BrdU (Abcam), and Desmin
(Chemicon). The CD24-biotin antibody used for immunohistochemistry was
obtained from BD PharMingen.
Labeling, Analysis, and Sorting of Adipose Stromal-Vascular Cells
Subcutaneous and parametrial adipose tissue was excised and the SVF
isolated as described (Rodbell, 1964). The isolated SVF was resuspended in
ice-cold Dulbecco’s modified Eagle’s medium (DMEM) with 2% fetal bovine
serum (FBS) for labeling. Antibody incubations were performed on ice for
15 min. Cells were washed and resuspended in Hank’s balanced salt solution
(HBSS) with 0.5 g/ml propidium iodide (Sigma-Aldrich) for sorting. BrdU incor-
poration was analyzed with the FITC BrdU Flow Kit (BD PharMingen) accord-
ing to the manufacturer’s protocol. Samples were sorted on a BD FACSAria
cell sorter and analyzed on a BD LSRII (BD Biosciences) flow cytometer,
each equipped with BD FACSDiva Software. For sorting, cells were initially
selected by size, on the basis of forward scatter (FSC) and side scatter
(SSC), followed by exclusion of dead cells on the basis of uptake of propidium
iodide. Then, live cells were gated on both SSC and FSC singlets, ensuring that
the staining of individual cells was analyzed. Next, the cells were separated on
the basis of the cell-surface markers indicated.
Culture and Differentiation of Primary Cells
Freshly isolated cells were plated onto laminin-coated plates (BD Biosciences)
in DMEM supplemented with 10% FBS (GIBCO) and 10 ng/mL bFGF (R&D
Systems) and maintained in a 5% CO2 atmosphere. Cells were allowed to
grow to confluence andwere then held at confluence for 2 dayswithout chang-
ing of themedia prior to exposure to the differentiation cocktail (1 mg/ml insulin,
0.25 mg/ml dexamethasone, and 0.5mM IBMX) in fresh media without addition
of bFGF. After 72 hr of exposure to the differentiation cocktail, cells weremain-
tained in DMEMwith 10% FBS until day 12 for harvest. For staining, cells were
fixed with 2% formaldehyde and 0.2% glutaraldehyde in PBS for 15 min and
then rinsed in PBS, water, and 60% isopropanol sequentially. The cells were
then stained with oil red O (0.7% in 60% isopropanol) for 10 min and rinsed
with 60% isopropanol followed by water. For gene expression analysis, RNA
was isolated with Trizol (Invitrogen) according to the manufacturer’s protocol.
Quantitative RT-PCR was performed by the Taqman system (Applied Biosys-
tems), with protocols and primers previously described (Birsoy et al., 2008a;
Chen et al., 2005). Data from RT-PCR analysis is shown as mean ± SEM.
Osteogenic and chondrogenic differentiation were performed as describedCell 135, 240–249, October 17, 2008 ª2008 Elsevier Inc. 247
(Boquest et al., 2005). Alkaline phosphatase activity was determined with an
alkaline phosphatase detection kit (Sigma-Aldrich). Myogenic differentiation
was performed as described (Lee et al., 2005). In brief, the isolated SVF sub-
fractions were mixed with myogenic C2C12 cells and then cultured in DMEM
supplemented with 20% serum overnight. The media was then changed to
DMEM with 1% FBS, and the cells were maintained for 5 days with media
changes every other day. The cells were then fixed in paraformaldehyde,
immunofluorescence was performed for desmin, and GFP fluorescence was
visualized directly.
Analysis of WAT
For immunohistochemistry, parametrial adipose tissuewas excised, fixed, and
paraffin-embedded as described (Cinti et al., 2001). Immunohistochemistry
was performed according to the VectaStain Elite ABC Kit protocols (Vector
Laboratories). Antibody staining was visualized with the metal-enhanced
DAB kit (Thermo Scientific). For immunohistochemical analysis of BrdU
incorporation, antigen retrieval was done under pressure in a 2100 Retriever
(PickCell Laboratories). Labeling of BrdU incorporation was done with the
FITC BrdU Flow Kit (BD PharMingen).
In Vivo Adipogenesis Assay
Sorted cells from the Lin:CD29+:CD34+:Sca-1+:CD24+, Lin:CD29+:CD34+:
Sca-1+:CD24, and Lin:CD29+:CD34 cell populations, or other populations
indicated in Table S2, were injected directly into the presumptive parametrial
adipose pad of 6- to 10-week-old A-Zip mice. Mice were anesthetized with
isoflurane prior to performance of surgery for exposure of the parametrial
(also known as reproductive or periuterine) WAT for injection. After the trans-
plant surgery, mice were allowed to recover, and blood glucose levels were
checked once weekly throughout the time course with the Ascensia Elite blood
glucose monitoring system (Bayer Healthcare). Luciferase imaging was per-
formed as described (Birsoy et al., 2008b) with an IVIS imaging system
(Caliper Lifesciences). After 12 weeks, the mice were sacrificed, injected
adipose tissue was excised, and serum was collected. Plasma protein levels
were determined with a mouse insulin ELISA kit (ALPCO Diagnostics) and
mouse adiponectin ELISA kit (R&DSystems). Wholemounts of the injected ad-
ipose pads were analyzed for expression of GFP with an Axiovert 200 inverted
microscope (Ziess).
SUPPLEMENTAL DATA
Supplemental Data include four figures and two tables and can be found with
this article online at http://www.cell.com/cgi/content/full/135/2/240/DC1/.
ACKNOWLEDGMENTS
The authors wish to thank Svetlana Mazel, Christopher Bare, and Xiaoxuan
Fan of the Rockefeller University Flow Cytometry Resource Center for their
expert assistance.
Received: May 22, 2008
Revised: August 14, 2008
Accepted: September 23, 2008
Published online: October 2, 2008
REFERENCES
Bernlohr, D.A., Bolanowski, M.A., Kelly, T.J., Jr., and Lane, M.D. (1985).
Evidence for an increase in transcription of specific mRNAs during differentia-
tion of 3T3-L1 preadipocytes. J. Biol. Chem. 260, 5563–5567.
Birsoy, K., Chen, Z., and Friedman, J. (2008a). Transcriptional regulation of
adipogenesis by KLF4. Cell Metab. 7, 339–347.
Birsoy, K., Soukas, A., Torrens, J., Ceccarini, G., Montez, J., Maffei, M.,
Cohen, P., Fayzikhodjaeva, G., Viale, A., Socci, N.D., and Friedman, J.M.
(2008b). Cellular program controlling the recovery of adipose tissue mass:
An in vivo imaging approach. Proc. Natl. Acad. Sci. USA 105, 12985–12990.248 Cell 135, 240–249, October 17, 2008 ª2008 Elsevier Inc.Boquest, A.C., Shahdadfar, A., Fronsdal, K., Sigurjonsson, O., Tunheim, S.H.,
Collas, P., and Brinchmann, J.E. (2005). Isolation and transcription profiling of
purified uncultured human stromal stem cells: alteration of gene expression
after in vitro cell culture. Mol. Biol. Cell 16, 1131–1141.
Brinster, R.L., and Zimmermann, J.W. (1994). Spermatogenesis followingmale
germ-cell transplantation. Proc. Natl. Acad. Sci. USA 91, 11298–11302.
Bryder, D., Rossi, D.J., and Weissman, I.L. (2006). Hematopoietic stem cells:
The paradigmatic tissue-specific stem cell. Am. J. Pathol. 169, 338–346.
Chen, Z., Torrens, J.I., Anand, A., Spiegelman, B.M., and Friedman, J.M.
(2005). Krox20 stimulates adipogenesis via C/EBPbeta-dependent
and -independent mechanisms. Cell Metab. 1, 93–106.
Cinti, S. (2005). The adipose organ. Prostaglandins Leukot. Essent. Fatty Acids
73, 9–15.
Cinti, S., Cigolini, M., Bosello, O., and Bjorntorp, P. (1984). A morphological
study of the adipocyte precursor. J. Submicrosc. Cytol. 16, 243–251.
Cinti, S., Zingaretti, M.C., Cancello, R., Ceresi, E., and Ferrara, P. (2001).
Morphologic techniques for the study of brown adipose tissue and white
adipose tissue. Methods Mol. Biol. 155, 21–51.
Deome, K.B., Faulkin, L.J., Jr., Bern, H.A., and Blair, P.B. (1959). Development
of mammary tumors from hyperplastic alveolar nodules transplanted into
gland-free mammary fat pads of female C3H mice. Cancer Res. 19, 515–520.
Fata, J.E., Chaudhary, V., and Khokha, R. (2001). Cellular turnover in the
mammary gland is correlated with systemic levels of progesterone and not
17beta-estradiol during the estrous cycle. Biol. Reprod. 65, 680–688.
Faust, I.M., Johnson, P.R., Stern, J.S., and Hirsch, J. (1978). Diet-induced
adipocyte number increase in adult rats: A new model of obesity. Am. J.
Physiol. 235, E279–E286.
Fischbach, C., Spruss, T., Weiser, B., Neubauer, M., Becker, C., Hacker, M.,
Gopferich, A., and Blunk, T. (2004). Generation of mature fat pads in vitro
and in vivo utilizing 3-D long-term culture of 3T3–L1 preadipocytes. Exp. Cell
Res. 300, 54–64.
Ford, C.E., Hamerton, J.L., Barnes, D.W., and Loutit, J.F. (1956). Cytological
identification of radiation-chimaeras. Nature 177, 452–454.
Gavrilova, O., Marcus-Samuels, B., Graham, D., Kim, J.K., Shulman, G.I.,
Castle, A.L., Vinson, C., Eckhaus, M., and Reitman, M.L. (2000). Surgical
implantation of adipose tissue reverses diabetes in lipoatrophic mice. J.
Clin. Invest. 105, 271–278.
Gesta, S., Tseng, Y.H., and Kahn, C.R. (2007). Developmental origin of fat:
Tracking obesity to its source. Cell 131, 242–256.
Gonzalez, F.J. (2005). Getting fat: Two new players in molecular adipogenesis.
Cell Metab. 1, 85–86.
Greenwood, M.R., and Hirsch, J. (1974). Postnatal development of adipocyte
cellularity in the normal rat. J. Lipid Res. 15, 474–483.
Hemmrich, K., von Heimburg, D., Rendchen, R., Di Bartolo, C., Milella, E., and
Pallua, N. (2005). Implantation of preadipocyte-loaded hyaluronic acid-based
scaffolds into nude mice to evaluate potential for soft tissue engineering.
Biomaterials 26, 7025–7037.
Hirsch, J., and Batchelor, B. (1976). Adipose tissue cellularity in human
obesity. Clin. Endocrinol. Metab. 5, 299–311.
Hong, L., Peptan, I.A., Colpan, A., and Daw, J.L. (2006). Adipose tissue
engineering by human adipose-derived stromal cells. Cells Tissues Organs
183, 133–140.
Hu, E., Liang, P., and Spiegelman, B.M. (1996). AdipoQ is a novel adipose-
specific gene dysregulated in obesity. J. Biol. Chem. 271, 10697–10703.
Izadpanah, R., Trygg, C., Patel, B., Kriedt, C., Dufour, J., Gimble, J.M., and
Bunnell, B.A. (2006). Biologic properties of mesenchymal stem cells derived
from bone marrow and adipose tissue. J. Cell. Biochem. 99, 1285–1297.
Johnson, P.R., Zucker, L.M., Cruce, J.A., and Hirsch, J. (1971). Cellularity of
adipose depots in the genetically obese Zucker rat. J. Lipid Res. 12, 706–714.
Kopelman, P.G. (2000). Obesity as a medical problem. Nature 404, 635–643.
Lane, M.D., and Tang, Q.Q. (2005). From multipotent stem cell to adipocyte.
Birth Defects Res. A. Clin. Mol. Teratol. 73, 476–477.
Lee, J.H., Kosinski, P.A., and Kemp, D.M. (2005). Contribution of human bone
marrow stem cells to individual skeletal myotubes followed by myogenic gene
activation. Exp. Cell Res. 307, 174–182.
Lee, R.H., Kim, B., Choi, I., Kim, H., Choi, H.S., Suh, K., Bae, Y.C., and Jung,
J.S. (2004). Characterization and expression analysis of mesenchymal stem
cells from human bone marrow and adipose tissue. Cell. Physiol. Biochem.
14, 311–324.
Lemonnier, D. (1970). Increase in number and size of adipose cells in nutritional
obesity in mice. Experientia 26, 974–975.
Lemonnier, D. (1972). Effect of age, sex, and sites on the cellularity of the
adipose tissue in mice and rats rendered obese by a high-fat diet. J. Clin.
Invest. 51, 2907–2915.
Li, C.L., and Johnson, G.R. (1995). Murine hematopoietic stem and progenitor
cells: I. Enrichment and biologic characterization. Blood 85, 1472–1479.
Mandrup, S., Loftus, T.M., MacDougald, O.A., Kuhajda, F.P., and Lane, M.D.
(1997). Obese gene expression at in vivo levels by fat pads derived from
s.c. implanted 3T3–F442A preadipocytes. Proc. Natl. Acad. Sci. USA 94,
4300–4305.
Moitra, J., Mason, M.M., Olive, M., Krylov, D., Gavrilova, O., Marcus-Samuels,
B., Feigenbaum, L., Lee, E., Aoyama, T., Eckhaus, M., et al. (1998). Life without
white fat: A transgenic mouse. Genes Dev. 12, 3168–3181.
Patrick, C.W., Jr., Chauvin, P.B., Hobley, J., and Reece, G.P. (1999). Preadipo-
cyte seeded PLGA scaffolds for adipose tissue engineering. Tissue Eng. 5,
139–151.
Rodbell, M. (1964). Metabolism of isolated fat cells. I. Effects of hormones on
glucose metabolism and lipolysis. J. Biol. Chem. 239, 375–380.
Rosen, E.D., and Spiegelman, B.M. (2006). Adipocytes as regulators of energy
balance and glucose homeostasis. Nature 444, 847–853.
Sengenes, C., Lolmede, K., Zakaroff-Girard, A., Busse, R., and Bouloumie, A.
(2005). Preadipocytes in the human subcutaneous adipose tissue display
distinct features from the adult mesenchymal and hematopoietic stem cells.
J. Cell. Physiol. 205, 114–122.
Shackleton, M., Vaillant, F., Simpson, K.J., Stingl, J., Smyth, G.K., Asselin-
Labat, M.L., Wu, L., Lindeman, G.J., and Visvader, J.E. (2006). Generation of
a functional mammary gland from a single stem cell. Nature 439, 84–88.
Simon, G. (1965). Histogenesis. In Handbook of Physiology. Section 5: Adi-
pose Tissue, A.E. Renold and G.F. Cahill, eds. (Washington, DC: American
Physiological Society).
Smith, G.H., andMedina, D. (1988). Amorphologically distinct candidate for an
epithelial stem cell in mouse mammary gland. J. Cell Sci. 90, 173–183.
Spalding, K.L., Arner, E., Westermark, P.O., Bernard, S., Buchholz, B.A.,
Bergmann, O., Blomqvist, L., Hoffstedt, J., Naslund, E., Britton, T., et al.
(2008). Dynamics of fat cell turnover in humans. Nature 453, 783–787.Spangrude, G.J., Heimfeld, S., and Weissman, I.L. (1988). Purification and
characterization of mouse hematopoietic stem cells. Science 241, 58–62.
Sun, S., Guo, Z., Xiao, X., Liu, B., Liu, X., Tang, P.H., and Mao, N. (2003).
Isolation of mouse marrow mesenchymal progenitors by a novel and reliable
method. Stem Cells 21, 527–535.
Tang, W., Zeve, D., Suh, J., Bosnakovski, D., Kyba, M., Hammer, B., Tallquist,
M.D., and Graff, J.M. (2008). White fat progenitor cells reside in the adipose
vasculature. Science, in press. Published online September 18, 2008. 10.
1126/science.1156232.
Thayer, K.A., Ruhlen, R.L., Howdeshell, K.L., Buchanan, D.L., Cooke, P.S.,
Preziosi, D., Welshons, W.V., Haseman, J., and vom Saal, F.S. (2001). Altered
prostate growth and daily sperm production in male mice exposed prenatally
to subclinical doses of 17alpha-ethinyl oestradiol. Hum. Reprod. 16, 988–996.
Trempus, C.S., Morris, R.J., Bortner, C.D., Cotsarelis, G., Faircloth, R.S.,
Reece, J.M., and Tennant, R.W. (2003). Enrichment for living murine keratino-
cytes from the hair follicle bulge with the cell surface marker CD34. J. Invest.
Dermatol. 120, 501–511.
Wagner, W., Wein, F., Seckinger, A., Frankhauser, M., Wirkner, U., Krause, U.,
Blake, J., Schwager, C., Eckstein, V., Ansorge, W., and Ho, A.D. (2005).
Comparative characteristics of mesenchymal stem cells from human bone
marrow, adipose tissue, and umbilical cord blood. Exp. Hematol. 33,
1402–1416.
Wassermann, F. (1926). The fat organs of man: Development, structure and
systematic placement of the so-called adipose tissue. Z. Zellforsch. Mikros-
kop. Anat. Abt. Histochem. 3, 325.
Wilson, A., Oser, G.M., Jaworski, M., Blanco-Bose, W.E., Laurenti, E., Adol-
phe, C., Essers, M.A., Macdonald, H.R., and Trumpp, A. (2007). Dormant
and self-renewing hematopoietic stem cells and their niches. Ann. N Y Acad.
Sci. 1106, 64–75.
Wise, A. (1975). Adipocyte number and size in hypothalamic obesity induced in
weanling mice by gold thioglucose and bipiperidyl mustard. Nutr. Metab. 19,
291–298.
Zhang, J.W., Klemm, D.J., Vinson, C., and Lane, M.D. (2004). Role of CREB in
transcriptional regulation of CCAAT/enhancer-binding protein beta gene
during adipogenesis. J. Biol. Chem. 279, 4471–4478.
Zheng, B., Cao, B., Li, G., and Huard, J. (2006). Mouse adipose-derived stem
cells undergo multilineage differentiation in vitro but primarily osteogenic and
chondrogenic differentiation in vivo. Tissue Eng. 12, 1891–1901.
Zuk, P.A., Zhu, M., Mizuno, H., Huang, J., Futrell, J.W., Katz, A.J., Benhaim, P.,
Lorenz, H.P., and Hedrick, M.H. (2001). Multilineage cells from human adipose
tissue: Implications for cell-based therapies. Tissue Eng. 7, 211–228.Cell 135, 240–249, October 17, 2008 ª2008 Elsevier Inc. 249
